Ergoteles’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Ergoteles’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,329,817	Closed	-$2.24M	–	986
2023 Q2	$2.24M	Buy	+2,329,817	New	+$2.3M	0.11%	246
2023 Q1	–	Sell	-51,196	Closed	-$18.9K	–	1948
2022 Q4	$18.9K	Sell	51,196 -330,706	-87%	-$139K	﹤0.01%	1347
2022 Q3	$164K	Sell	381,902 -362,373	-49%	-$356K	0.01%	1247
2022 Q2	$581K	Buy	744,275 +445,270	+149%	+$392K	0.02%	774
2022 Q1	$386K	Buy	+299,005	New	+$275K	0.01%	763
2021 Q4	–	Sell	-63,300	Closed	-$138K	–	1705
2021 Q3	$138K	Buy	+63,300	New	+$173K	0.01%	1065

Ergoteles's SPPI Position: Q3 2023 in Review

Ergoteles sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 2,329,817 shares — an estimated $2.24M sold.

Ergoteles first reported a position in SPPI in Q3 2021 and held it in 6 quarters. The position peaked at $2.24M in Q2 2023. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

Ergoteles reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 2,329,817 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $2.24M.
Ergoteles first reported a position in Spectrum Pharmaceuticals Inc in Q3 2021 and held it in 6 quarters.
Ergoteles's Spectrum Pharmaceuticals Inc position peaked at $2.24M in Q2 2023.
0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.